HealthStream (NASDAQ:HSTM) CEO Robert Frist, Jr. Sells 144,068 Shares

HealthStream, Inc. (NASDAQ:HSTM) CEO Robert Frist, Jr. sold 144,068 shares of the company’s stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $29.50, for a total transaction of $4,250,006.00. Following the transaction, the chief executive officer owned 3,907,038 shares of the company’s stock, valued at $115,257,621. This represents a 3.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

HealthStream Trading Up 0.1%

NASDAQ:HSTM traded up $0.02 during mid-day trading on Tuesday, hitting $29.65. The stock had a trading volume of 202,612 shares, compared to its average volume of 262,836. The stock has a market capitalization of $866.22 million, a price-to-earnings ratio of 41.18, a P/E/G ratio of 3.37 and a beta of 0.44. The company has a 50 day simple moving average of $28.61 and a 200-day simple moving average of $25.02. HealthStream, Inc. has a 52 week low of $19.50 and a 52 week high of $31.11.

HealthStream (NASDAQ:HSTM) last posted its earnings results on Monday, August 3rd. The technology company reported $0.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.06. HealthStream had a net margin of 6.60% and a return on equity of 6.81%. The firm had revenue of $83.73 million during the quarter, compared to analyst estimates of $80.82 million. As a group, equities research analysts anticipate that HealthStream, Inc. will post 0.72 earnings per share for the current year.

HealthStream Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 28th. Stockholders of record on Monday, August 17th were given a dividend of $0.035 per share. The ex-dividend date was Monday, August 17th. This represents a $0.14 annualized dividend and a dividend yield of 0.5%. HealthStream’s payout ratio is currently 19.44%.

Wall Street Analysts Forecast Growth

Several analysts recently commented on HSTM shares. Wall Street Zen upgraded HealthStream from a “hold” rating to a “buy” rating in a research report on Sunday, August 30th. Weiss Ratings upgraded HealthStream from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, August 28th. Finally, Canaccord Genuity Group increased their price target on HealthStream from $24.00 to $27.00 and gave the stock a “hold” rating in a research note on Tuesday, July 21st. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $27.00.

Institutional Trading of HealthStream

Hedge funds and other institutional investors have recently made changes to their positions in the stock. MassMutual Private Wealth & Trust FSB lifted its stake in shares of HealthStream by 76.4% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,025 shares of the technology company’s stock worth $28,000 after acquiring an additional 444 shares during the period. Integrated Wealth Concepts LLC acquired a new position in shares of HealthStream during the second quarter valued at approximately $27,000. Global Retirement Partners LLC bought a new stake in HealthStream during the second quarter worth approximately $31,000. Essential Partners LLC bought a new stake in HealthStream during the first quarter worth approximately $25,000. Finally, Hantz Financial Services Inc. lifted its position in HealthStream by 2,035.5% in the fourth quarter. Hantz Financial Services Inc. now owns 1,324 shares of the technology company’s stock worth $31,000 after purchasing an additional 1,262 shares during the period. 69.58% of the stock is currently owned by institutional investors.

HealthStream Company Profile

HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its cloud-based offerings help hospitals, health systems and other healthcare providers manage employee training, education, credentialing, compliance and professional development.

The company’s products and services include learning and talent-management tools, provider credentialing and enrollment solutions, performance assessment, clinical development resources, and patient-experience measurement services.